<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02600676</url>
  </required_header>
  <id_info>
    <org_study_id>020891</org_study_id>
    <nct_id>NCT02600676</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis</brief_title>
  <official_title>Randomized, Double Blind, Placebo Controlled Trial of Sacral Transcutaneous Electric Nerve Stimulation (TENS) in Children With Enuresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double blind, placebo controlled study of the effect of Sacral
      Transcutaneous Electric Nerve Stimulation (TENS) in fifty-two children with monosymptomatic
      nocturnal enuresis (MNE).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives:

      Nighttime urinary incontinence (enuresis) is seen by 5-10% of children from six to fifteen
      years. Enuresis is a socially and psychologically stressful condition that can lead to
      bullying and low self esteem. Today the condition is treated with desmopressin or bells, that
      awake children at nighttime urination. One third of children suffering from enuresis are
      refractory to first line of treatment. Transcutaneous Electric Nerve Stimulation (TENS) has
      been documented efficacious on symptoms in children with daytime incontinence. Little is
      known regarding the effect of TENS on monosymptomatic nocturnal enuresis (MNE). The aim of
      our study is to investigate the effect of TENS on children diagnosed with MNE.

      Methods:

      This is a randomized, double blind, placebo controlled study of the effect of TENS in
      fifty-two children with MNE. The study period is from September 2015 to September 2016. The
      children recruited will receive TENS one hour during daytime and one hour during sleep for a
      total treatment period of ten weeks. The surface electrodes will be placed on the skin over
      s2-s3. TENS is safe and not associated with adverse effects.

      Expected results:

      The investigators hypothesize a reduction in number of wet nights in the enuretic children
      receiving active TENS. If TENS proves effective in children with enuresis it will be
      implemented as part of enuresis treatment in the clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of wet nights</measure>
    <time_frame>1 year</time_frame>
    <description>Non-response is a reduction in wet nights &lt; 50%, partial response a reduction of 50-89%, response a reduction of 90-99% and full response a reduction of 100% or less than one wet night in a month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum voided volume though daytime (MVV)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nighttime urine production (NUP) on wet nights</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of wet night where NUP &lt; MVV</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Enuresis</condition>
  <condition>Nocturnal Enuresis</condition>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>TENS, 10 weeks (active) 2 hours a day.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>26 children.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TENS, 10 weeks (placebo) 2 hours a day.</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>26 children.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electric Nerve Stimulation (TENS) - active</intervention_name>
    <description>TENS is a non-invasive method using surface electrodes. Except a few cases with local skin irritation in the area where the electrodes are applied, there is no evidence of side effects of TENS treatment.</description>
    <arm_group_label>TENS, 10 weeks (active) 2 hours a day.</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous Electric Nerve Stimulation (TENS) - placebo</intervention_name>
    <arm_group_label>TENS, 10 weeks (placebo) 2 hours a day.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Unremarkable clinical examination

          -  3 or more wet nights per week

          -  No treatment of enuresis 1 week before the treatment starts (for bells two weeks)

        Exclusion Criteria:

          -  Nighttime urine production on wet nights &gt; 130 % of &quot;maximum voided volume&quot; (MVV) for
             age

          -  Ongoing constipation and/or faecal incontinence that are not successfully treated

          -  Daytime incontinence

          -  Prior or ongoing treatment with TENS

          -  Current or previous clinical history, clinical or laboratory findings or daily
             treatment with drugs that can be related to diseases or conditions that are expected
             to change the parameters investigated, especially diseases of the kidney and urinary
             tract or endocrine disorder

          -  Neurological and/or significant anatomical abnormalities of the urinary tract

          -  Previous operation in the urinary tract

          -  Recurrent urinary tract infections

          -  Incomplete bladder emptying (assessed with ultrasound) which means post micturition
             urine volume in the bladder &gt; 20 ml or &gt; 10 % of the total urine production
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Søren Rittig, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital, Skejby</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Culbert TP, Banez GA. Wetting the bed: integrative approaches to nocturnal enuresis. Explore (NY). 2008 May-Jun;4(3):215-20. doi: 10.1016/j.explore.2008.02.014. Review.</citation>
    <PMID>18466855</PMID>
  </reference>
  <reference>
    <citation>Hägglöf B, Andrén O, Bergström E, Marklund L, Wendelius M. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol. 1998;33 Suppl 3:16-9.</citation>
    <PMID>9599731</PMID>
  </reference>
  <reference>
    <citation>Kamperis K, Hagstroem S, Rittig S, Djurhuus JC. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis. J Urol. 2008 Mar;179(3):1128-31. doi: 10.1016/j.juro.2007.10.088. Epub 2008 Jan 18.</citation>
    <PMID>18206924</PMID>
  </reference>
  <reference>
    <citation>Yeung CK, Sreedhar B, Sihoe JD, Sit FK, Lau J. Differences in characteristics of nocturnal enuresis between children and adolescents: a critical appraisal from a large epidemiological study. BJU Int. 2006 May;97(5):1069-73.</citation>
    <PMID>16643494</PMID>
  </reference>
  <reference>
    <citation>Rittig S, Frøkiaer J. Basis and therapeutical rationale of the urinary concentrating mechanism. Int J Clin Pract Suppl. 2007 Sep;(155):2-7. Review.</citation>
    <PMID>17727573</PMID>
  </reference>
  <reference>
    <citation>Negoro H, Kanematsu A, Doi M, Suadicani SO, Matsuo M, Imamura M, Okinami T, Nishikawa N, Oura T, Matsui S, Seo K, Tainaka M, Urabe S, Kiyokage E, Todo T, Okamura H, Tabata Y, Ogawa O. Involvement of urinary bladder Connexin43 and the circadian clock in coordination of diurnal micturition rhythm. Nat Commun. 2012 May 1;3:809. doi: 10.1038/ncomms1812.</citation>
    <PMID>22549838</PMID>
  </reference>
  <reference>
    <citation>Bower WF, Moore KH, Adams RD, Shepherd R. A urodynamic study of surface neuromodulation versus sham in detrusor instability and sensory urgency. J Urol. 1998 Dec;160(6 Pt 1):2133-6.</citation>
    <PMID>9817339</PMID>
  </reference>
  <reference>
    <citation>Hasan ST, Robson WA, Pridie AK, Neal DE. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability. J Urol. 1996 Jun;155(6):2005-11.</citation>
    <PMID>8618309</PMID>
  </reference>
  <reference>
    <citation>Appell RA. Electrical stimulation for the treatment of urinary incontinence. Urology. 1998 Feb;51(2A Suppl):24-6. Review.</citation>
    <PMID>9495731</PMID>
  </reference>
  <reference>
    <citation>Hagstroem S, Mahler B, Madsen B, Djurhuus JC, Rittig S. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence. J Urol. 2009 Oct;182(4 Suppl):2072-8. doi: 10.1016/j.juro.2009.05.101. Epub 2009 Aug 20.</citation>
    <PMID>19695629</PMID>
  </reference>
  <reference>
    <citation>Hagstroem S, Rittig N, Kamperis K, Mikkelsen MM, Rittig S, Djurhuus JC. Treatment outcome of day-time urinary incontinence in children. Scand J Urol Nephrol. 2008;42(6):528-33. doi: 10.1080/00365590802098367.</citation>
    <PMID>18609267</PMID>
  </reference>
  <reference>
    <citation>Bower WF, Moore KH, Adams RD. A pilot study of the home application of transcutaneous neuromodulation in children with urgency or urge incontinence. J Urol. 2001 Dec;166(6):2420-2.</citation>
    <PMID>11696802</PMID>
  </reference>
  <reference>
    <citation>Hoebeke P, Van Laecke E, Everaert K, Renson C, De Paepe H, Raes A, Vande Walle J. Transcutaneous neuromodulation for the urge syndrome in children: a pilot study. J Urol. 2001 Dec;166(6):2416-9.</citation>
    <PMID>11696801</PMID>
  </reference>
  <reference>
    <citation>De Gennaro M, Capitanucci ML, Mastracci P, Silveri M, Gatti C, Mosiello G. Percutaneous tibial nerve neuromodulation is well tolerated in children and effective for treating refractory vesical dysfunction. J Urol. 2004 May;171(5):1911-3.</citation>
    <PMID>15076308</PMID>
  </reference>
  <reference>
    <citation>Malm-Buatsi E, Nepple KG, Boyt MA, Austin JC, Cooper CS. Efficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapy. Urology. 2007 Nov;70(5):980-3. Epub 2007 Oct 24.</citation>
    <PMID>17919697</PMID>
  </reference>
  <reference>
    <citation>Lordêlo P, Teles A, Veiga ML, Correia LC, Barroso U Jr. Transcutaneous electrical nerve stimulation in children with overactive bladder: a randomized clinical trial. J Urol. 2010 Aug;184(2):683-9. doi: 10.1016/j.juro.2010.03.053. Epub 2010 Jun 18.</citation>
    <PMID>20561643</PMID>
  </reference>
  <reference>
    <citation>Lordêlo P, Soares PV, Maciel I, Macedo A Jr, Barroso U Jr. Prospective study of transcutaneous parasacral electrical stimulation for overactive bladder in children: long-term results. J Urol. 2009 Dec;182(6):2900-4. doi: 10.1016/j.juro.2009.08.058. Epub 2009 Oct 28.</citation>
    <PMID>19846164</PMID>
  </reference>
  <reference>
    <citation>Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J Urol. 1988 Dec;140(6):1331-9. Review.</citation>
    <PMID>3057221</PMID>
  </reference>
  <reference>
    <citation>Elabbady AA, Hassouna MM, Elhilali MM. Neural stimulation for chronic voiding dysfunctions. J Urol. 1994 Dec;152(6 Pt 1):2076-80.</citation>
    <PMID>7966678</PMID>
  </reference>
  <reference>
    <citation>Bower WF, Yeung CK. A review of non-invasive electro neuromodulation as an intervention for non-neurogenic bladder dysfunction in children. Neurourol Urodyn. 2004;23(1):63-7. Review.</citation>
    <PMID>14694460</PMID>
  </reference>
  <reference>
    <citation>Nevéus T, von Gontard A, Hoebeke P, Hjälmås K, Bauer S, Bower W, Jørgensen TM, Rittig S, Walle JV, Yeung CK, Djurhuus JC. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society. J Urol. 2006 Jul;176(1):314-24.</citation>
    <PMID>16753432</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2015</study_first_submitted>
  <study_first_submitted_qc>November 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2015</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publication</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

